Join to View Full Profile
Beth Israel Deaconess Medical Center330 Brookline AvenueBoston, MA 02215
Phone+1 617-975-5000
Are you Dr. Pandya?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shuchi Pandya, MD is an oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Instructor in Medicine at Beth Israel Deaconess Medical Center.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2003 - 2006
Tufts University School of MedicineClass of 2003
Certifications & Licensure
MA State Medical License 2006 - 2026
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsPharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study.Bin Fan, Ghassan K Abou-Alfa, Andrew X Zhu, Shuchi S Pandya, Hongxia Jia
Cancer Chemotherapy and Pharmacology. 2024-05-01 - 3 citationsSafety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.Courtney D DiNardo, Stéphane De Botton, Daniel A Pollyea, Richard M Stone, Jessica K Altman
American Journal of Hematology. 2023-09-01 - 9 citationsVolumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of Ivosidenib.Benjamin M. Ellingson, Grace Kim, Matthew S. Brown, Jihey Lee, Noriko Salamon
Neuro-Oncology. 2021-11-09
